Steven Serneels

GSG Impact builds impact economies. We do this by working to embed social and environmental impact at the heart of every political, investment, business and consumption decision. We connect global leaders, governments, investors, regulators and social innovators, so that together we can build the infrastructure and incentives for social and environmental impact to be central to all decision making. GSG Impact is the cornerstone of the wider GSG Impact Partnership – a global network of 43 National Partners representing 48 countries: more than half in emerging markets.

G1000 is a Belgian platform for democratic innovation. We develop, support and promote new forms of deliberation that reinforce democracy from the local to the national level. We believe democracy should give more space to regular citizens.

The Impact Investing Institute was launched in 2019 with a simple mission: to accelerate the growth and improve the effectiveness of the impact investing market in the UK and internationally. Our aim is for capital markets to be fairer and work better for people and the planet, in order to deliver sustainable and inclusive economic growth.

SI2 Fund is a European impact investment fund backing social enterprises that offer breakthrough solutions to the societal challenges of our time. Inventive social enterprises that built a better future for people and planet, while generating a healthy revenue. SI2 Fund is a Shaping Impact Group fund. We enable our portfolio companies to grow their business and increase their impact. With tailored funding, active guidance and access to a wide network. As dedicated partners, we help create a high societal value alongside a fair financial return for both the enterprise and investors. SI2 Fund is an impact-first fund, and first of its kind in the Benelux. We are mainly operating in Belgium, The Netherlands, United-Kingdom and neighbouring countries. ➡ Subscribe to our newsletter ⬅ Discover the latest news, tips, events and interesting reads of SI2 Fund and the impact community: http://eepurl.com/c4k45L

GSG Impact builds impact economies. We do this by working to embed social and environmental impact at the heart of every political, investment, business and consumption decision. We connect global leaders, governments, investors, regulators and social innovators, so that together we can build the infrastructure and incentives for social and environmental impact to be central to all decision making. GSG Impact is the cornerstone of the wider GSG Impact Partnership – a global network of 43 National Partners representing 48 countries: more than half in emerging markets.

We believe finance can and should be a force for Good. With only 5% of total assets invested by Belgian funds having sustainable investing as their objective, join us to explore and define together the future of Impact Financing.

G1000 is a Belgian platform for democratic innovation. We develop, support and promote new forms of deliberation that reinforce democracy from the local to the national level. We believe democracy should give more space to regular citizens.

The Impact Investing Institute was launched in 2019 with a simple mission: to accelerate the growth and improve the effectiveness of the impact investing market in the UK and internationally. Our aim is for capital markets to be fairer and work better for people and the planet, in order to deliver sustainable and inclusive economic growth.

The Institute of Tropical Medicine in Antwerp, Belgium (ITM) is one of the world's leading institutes for training, research and assistance in tropical medicine and health care in developing countries. The ITM houses three scientific departments, a specialised outpatient clinic and various support services, and employs over 400 staff. The institute draws its core funding from the Flemish Ministries of Education and Science, and the Federal Ministries of Development Cooperation, Public Health and Social Affairs, international project financing and own income. The ITM works with many scientific institutions, governments and organisations all over the world for a long-lasting improvement of health care and disease control in developing countries.